In conclusion, we demonstrated MSC-based KGF gene therapy can attenuate pathological damage and alleviate the inflammatory response and pulmonary vascular permeability in an LPS-induced ALI mice model. Here, FGF7 is linked to acute respiratory distress syndrome.